Novo Nordisk will discontinue its weight loss medication Saxenda in January 2027. People who currently take Saxenda for ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...
Saxenda, which is injected daily, is the only form of GLP-1 therapy which is reimbursed for weight loss by the HSE, free ...
Emily McNutt is a journalist and editorial leader with extensive experience covering a range of topics from travel rewards to product reviews and financial news. With a passion for accurate reporting ...
In a new study published in the JAMA Network Open medical journal, Novo Nordisk A/S’s (NYSE:NVO) Saxenda (liraglutide), an earlier-generation weight loss drug, reveals significant declines in bone ...
OVER 200 deaths linked to the blockbuster weight loss jabs Mounjaro and Wegovy have now been reported. There have also been 15,000 reports of “serious” adverse effects to the fat jabs, ...